AstraZeneca
in lung cancer ambition for of lung cancer patients to be eligible for medicine by leading the future of lung cancer treatment establishing as backbone in leading in advancing best in class to replace systemic chemotherapy delivering next wave to improve on developing novel combinations including investing behind new technologies and platforms including cell therapy and testing screening | AstraZeneca
Company
Deck Type
Deck date
November 2024
Slide
30 of 38
Similar slides by AstraZeneca
Investor Event
September 2024
Results
February 2024
Results
November 2023
Results
July 2023
Related slides by other companies
Investor Presentation
February 2024
Results
April 2021
Results
June 2022
Results
August 2021
Other recent decks by AstraZeneca
Results
February 2025
Results
November 2024
Investor Event
September 2024
Results
February 2024
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2024 Slidebook.io